Bausch Health Companies Inc (BHC) is a publicly traded Healthcare sector company. As of May 21, 2026, BHC trades at $5.50 with a market cap of $1.99B and a P/E ratio of 13.20. BHC moved +3.48% today. Year to date, BHC is -25.68%; over the trailing twelve months it is +17.52%. Its 52-week range spans $4.25 to $9.85. Analyst consensus is neutral with an average price target of $7.00. Rallies surfaces BHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bausch Health Companies Inc (BHC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BHC moved +3.48% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $5.50 |
| Market Cap | $1.99B |
| P/E Ratio | 13.20 |
| EPS | $0.42 |
| Dividend Yield | 1.00% |
| 52-Week High | $9.85 |
| 52-Week Low | $4.25 |
| Volume | 1.71M |
| Avg Volume | 0 |
| Revenue (TTM) | $10.27B |
| Net Income | $120.00M |
| Gross Margin | 0.00% |
6 analysts cover BHC: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.00.